Detalhe da pesquisa
1.
Assessing the need for routine safety testing for patients being treated with dupilumab for moderate-to-severe atopic dermatitis.
Br J Dermatol
; 182(6): e186-e209, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32476149
2.
Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS).
Br J Dermatol
; 182(5): 1120-1135, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31407311
3.
Efficacy and safety of dupilumab in Japanese adults with moderate-to-severe atopic dermatitis: a subanalysis of three clinical trials.
Br J Dermatol
; 183(1): 39-51, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31564057
4.
Dupilumab in adolescents with uncontrolled moderate-to-severe atopic dermatitis: results from a phase IIa open-label trial and subsequent phase III open-label extension.
Br J Dermatol
; 182(1): 85-96, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31595499
5.
Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials.
Br J Dermatol
; 181(1): 80-87, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30791102
6.
Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis.
Br J Dermatol
; 181(4): 761-769, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30729499
7.
Conjunctivitis in dupilumab clinical trials.
Br J Dermatol
; 181(3): 459-473, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30851191
8.
Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).
Br J Dermatol
; 178(5): e332-e341, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29672835
9.
Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).
Br J Dermatol
; 175(1): 69-79, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27436240
10.
Dupilumab significantly improves sleep outcomes in adult patients with atopic dermatitis: results from five randomized clinical trials.
J Eur Acad Dermatol Venereol
; 35(2): e130-e133, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32789996
11.
Response to R. Waldman et al.: 'Does IL-4 inhibition play a role in dupilumab-associated conjunctivitis?'
Br J Dermatol
; 182(5): 1310-1312, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31853960
12.
Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomical regions: data from phase III clinical trials.
Br J Dermatol
; 181(1): 196-197, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30719707
13.
Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME).
Br J Dermatol
; 171(6): 1318-25, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24980543
14.
Exploratory Population PK Analysis of Dupilumab, a Fully Human Monoclonal Antibody Against IL-4Rα, in Atopic Dermatitis Patients and Normal Volunteers.
CPT Pharmacometrics Syst Pharmacol
; 5(11): 617-624, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27778477
15.
[Investigations of the left ventricular dynamics in stable-angina pectoris (AP)]. / Explorarea dinamicii ventriculare stîngi în angina pectorala stabile.
Rev Med Chir Soc Med Nat Iasi
; 86(2): 243-8, 1982.
Artigo
em Ro
| MEDLINE | ID: mdl-25588243
16.
["Minor" salmonelloses on the offensive; clinico-epidemiological aspects of Salmonella agona infections]. / Salmonelozele "minore" in ofensiva, aspecte clinicoepidemiologice ale infectiei cu Salmonella agona.
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol
; 25(3): 149-58, 1980.
Artigo
em Ro
| MEDLINE | ID: mdl-7433813
17.
[Renal lithiasis. Current data on its etiopathogenesis and the therapeutic prospects]. / Litiaza renala. Date actuale de etiopatogenie si perspective terapeutice.
Rev Med Chir Soc Med Nat Iasi
; 88(3): 565-8, 1984.
Artigo
em Ro
| MEDLINE | ID: mdl-6545461
18.
[Biorhythmical variations in the eruption of the deciduous teeth]. / Les variations biorythmiques de l'éruption des dents temporaires.
Bull Group Int Rech Sci Stomatol
; 15(2): 193-206, 1972 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-4506682
19.
[Reactive depression in mourning--clinico-therapeutic aspects]. / Depresii reactive de doliu--aspecte clinicoterapeutice.
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir
; 32(3): 205-18, 1987.
Artigo
em Ro
| MEDLINE | ID: mdl-2962258
20.
[102 cases of hemiblock (fascicular blocks). Electrocardiographic aspects and clinical significance]. / Consideratii pe marginea a 102 cazuri de hemibloc (blocuri fasciculare. Aspecte electrocardiografice si semnifcatie clinica
Rev Med Chir Soc Med Nat Iasi
; 79(3): 345-53, 1975.
Artigo
em Ro
| MEDLINE | ID: mdl-1188213